Adagio Therapeutics Inc. Made Headway
Wed, Mar 30, 2022 at 05:30 PM
Adagio Therapeutics Inc. (ADGI:NASDAQ) shot up at $5.02, representing a gain of 30.4%. The stock got featured on our News Catalysts scanner on Wed, Mar 30, 2022 at 01:22 PM in the 'MISCELLANEOUS' category. From Wed, Mar 16, 2022, the stock recorded 22.22% Up Days and 30.00% Green Days
The stock spiked on Wed, Feb 09, 2022 at $12.1 with a volume of 6M+.
About Adagio Therapeutics Inc. (ADGI:NASDAQ)
Adagio Therapeutics Inc is a clinical-stage biopharmaceutical company.
Top 10 Gainers:
- Forge Global Holdings Inc. (FRGE:NYSE), 73.94%
- Direct Digital Holdings Inc. (DRCT:NASDAQ), 60.47%
- Hillstream BioPharma Inc. (HILS:NASDAQ), 39.04%
- Adagio Therapeutics Inc. (ADGI:NASDAQ), 30.39%
- Mullen Automotive Inc. (MULN:NASDAQ), 28.94%
- Insignia Systems, Inc. (ISIG:NASDAQ), 27.28%
- Geron Corporation (GERN:NASDAQ), 25%
- Snow Lake Resources Ltd. (LITM:NASDAQ), 24.76%
- Dogness (International) Corporation (DOGZ:NASDAQ), 22.06%
- TMC the metals company Inc. (TMC:NASDAQ), 21.23%